company background image
2275 logo

Guilin Sanjin Pharmaceutical SZSE:002275 Stock Report

Last Price

CN¥12.93

Market Cap

CN¥7.7b

7D

-1.0%

1Y

-27.9%

Updated

13 Jun, 2024

Data

Company Financials +

Guilin Sanjin Pharmaceutical Co., Ltd.

SZSE:002275 Stock Report

Market Cap: CN¥7.7b

2275 Stock Overview

Engages in the research, production, and sale of traditional Chinese and natural medicines in China.

2275 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance3/6
Financial Health5/6
Dividends4/6

Guilin Sanjin Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guilin Sanjin Pharmaceutical
Historical stock prices
Current Share PriceCN¥12.93
52 Week HighCN¥18.45
52 Week LowCN¥11.28
Beta0.39
1 Month Change-13.74%
3 Month Change-10.40%
1 Year Change-27.89%
3 Year Change-0.46%
5 Year Change-5.62%
Change since IPO-53.32%

Recent News & Updates

Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30

May 23
Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30

Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity

May 22
Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity

Recent updates

Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30

May 23
Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30

Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity

May 22
Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity

Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?

Apr 17
Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?

Shareholder Returns

2275CN PharmaceuticalsCN Market
7D-1.0%-0.8%-0.9%
1Y-27.9%-9.9%-14.4%

Return vs Industry: 002275 underperformed the CN Pharmaceuticals industry which returned -9.9% over the past year.

Return vs Market: 002275 underperformed the CN Market which returned -14.4% over the past year.

Price Volatility

Is 2275's price volatile compared to industry and market?
2275 volatility
2275 Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 002275 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002275's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19672,615n/awww.sanjin.com.cn

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. Guilin Sanjin Pharmaceutical Co., Ltd.

Guilin Sanjin Pharmaceutical Co., Ltd. Fundamentals Summary

How do Guilin Sanjin Pharmaceutical's earnings and revenue compare to its market cap?
2275 fundamental statistics
Market capCN¥7.73b
Earnings (TTM)CN¥352.09m
Revenue (TTM)CN¥1.94b

21.6x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2275 income statement (TTM)
RevenueCN¥1.94b
Cost of RevenueCN¥546.92m
Gross ProfitCN¥1.39b
Other ExpensesCN¥1.04b
EarningsCN¥352.09m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.60
Gross Margin71.78%
Net Profit Margin18.17%
Debt/Equity Ratio12.9%

How did 2275 perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

100%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.